Brief: Hamlet Pharma In Discussions With Companies On LoI
Nov 17 (Reuters) - Hamlet Pharma AB HAMLET.TE :
* IS CURRENTLY IN DISCUSSIONS WITH MAJOR MULTINATIONAL
COMPANIES
ON LETTERS OF INTENT INCLUDING EVALUATION- AND DEVELOPMENT OF
PROCESSES FOR A POTENTIAL, FUTURE COMMERCIAL USE OF BAMLET IN
NON-PRESCRIPTION AND FOOD PRODUCTS
Source text for Eikon: ID:nWkr80QcVQ
Further company coverage: HAMLET.TE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587785110;))